» Articles » PMID: 38106405

Exosomal MiRNAs in Autoimmune Skin Diseases

Overview
Journal Front Immunol
Date 2023 Dec 18
PMID 38106405
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes, bilaterally phospholipid-coated small vesicles, are produced and released by nearly all cells, which comprise diverse biological macromolecules, including proteins, DNA, RNA, and others, that participate in the regulation of their biological functions. An increasing number of studies have revealed that the contents of exosomes, particularly microRNA(miRNA), play a significant role in the pathogenesis of various diseases, including autoimmune skin diseases. MiRNA is a class of single-stranded non-coding RNA molecules that possess approximately 22 nucleotides in length with the capability of binding to the untranslated as well as coding regions of target mRNA to regulate gene expression precisely at the post-transcriptional level. Various exosomal miRNAs have been found to be significantly expressed in some autoimmune skin diseases and involved in the pathogenesis of conditions via regulating the secretion of crucial pathogenic cytokines and the direction of immune cell differentiation. Thus, exosomal miRNAs might be promising biomarkers for monitoring disease progression, relapse and reflection to treatment based on their functions and changes. This review summarized the current studies on exosomal miRNAs in several common autoimmune skin diseases, aiming to dissect the underlying mechanism from a new perspective, seek novel biomarkers for disease monitoring and lay the foundation for developing innovative target therapy in the future.

Citing Articles

Expression profiles of miR-101-3p and miR-431-5p as potential diagnostic biomarkers for rheumatoid arthritis.

Sadaty M, Mekhemer S, Abdel-Ghany S, El-Ansary A, Mohamed R, Kamal N Sci Rep. 2025; 15(1):776.

PMID: 39755725 PMC: 11700103. DOI: 10.1038/s41598-024-82339-1.


Exploring the reality of exosomes in dermatology.

DalForno-Dini T, Birck M, Rocha M, Bagatin E An Bras Dermatol. 2024; 100(1):121-130.

PMID: 39562240 PMC: 11745280. DOI: 10.1016/j.abd.2024.09.002.


Exosomes as Vehicles for Noncoding RNA in Modulating Inflammation: A Promising Regulatory Approach for Ischemic Stroke and Myocardial Infarction.

Lai Z, Ye T, Zhang M, Mu Y J Inflamm Res. 2024; 17:7485-7501.

PMID: 39464334 PMC: 11505480. DOI: 10.2147/JIR.S484119.


Exosome-derived microRNAs: emerging players in vitiligo.

Li W, Pang Y, He Q, Song Z, Xie X, Zeng J Front Immunol. 2024; 15:1419660.

PMID: 39040109 PMC: 11260631. DOI: 10.3389/fimmu.2024.1419660.


Recent progress of exosomal lncRNA/circRNA-miRNA-mRNA axis in lung cancer: implication for clinical application.

Wang R, Xu Y, Tong L, Zhang X, Zhang S Front Mol Biosci. 2024; 11:1417306.

PMID: 39021878 PMC: 11251945. DOI: 10.3389/fmolb.2024.1417306.


References
1.
Baral H, Uchiyama A, Yokoyama Y, Sekiguchi A, Yamazaki S, Amalia S . Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p. J Dermatol Sci. 2021; 104(1):39-47. DOI: 10.1016/j.jdermsci.2021.08.006. View

2.
Luo H, Xie B, Xu J, Zhu Y, Sun J, Shen Y . Differential Expression of Serum Exosomal Hsa-miR-487b-3p in Progressive Vitiligo Before and After Systemic Corticosteroid Treatment. Clin Cosmet Investig Dermatol. 2022; 15:1377-1386. PMC: 9307869. DOI: 10.2147/CCID.S372112. View

3.
Tu J, Zheng N, Mao C, Liu S, Zhang H, Sun L . UC-BSCs Exosomes Regulate Th17/Treg Balance in Patients with Systemic Lupus Erythematosus via miR-19b/KLF13. Cells. 2022; 11(24). PMC: 9777319. DOI: 10.3390/cells11244123. View

4.
Sung M, Sung S, Kang K, Choi J, Lee S, Kim K . Serum-Derived Neuronal Exosomal microRNAs as Stress-Related Biomarkers in an Atopic Dermatitis Model. Biomedicines. 2021; 9(12). PMC: 8698818. DOI: 10.3390/biomedicines9121764. View

5.
Beck L, Cork M, Amagai M, Benedetto A, Kabashima K, Hamilton J . Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis. JID Innov. 2022; 2(5):100131. PMC: 9428921. DOI: 10.1016/j.xjidi.2022.100131. View